These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 37925534

  • 1. Circulating miRNAs signature on breast cancer: the MCC-Spain project.
    Gómez-Acebo I, Llorca J, Alonso-Molero J, Díaz-Martínez M, Pérez-Gómez B, Amiano P, Belmonte T, Molina AJ, Burgui R, Castaño-Vinyals G, Moreno V, Molina-Barceló A, Marcos-Gragera R, Kogevinas M, Pollán M, Dierssen-Sotos T.
    Eur J Med Res; 2023 Nov 04; 28(1):480. PubMed ID: 37925534
    [Abstract] [Full Text] [Related]

  • 2. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR, Mohan SV, Lu Ping T, Tengku Din TADAAB, Haron J, Romli RC, Jaafar H, Nafi SN, Tuan Salwani TI, Yahya MM.
    Asian Pac J Cancer Prev; 2021 May 01; 22(5):1375-1381. PubMed ID: 34048164
    [Abstract] [Full Text] [Related]

  • 3. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H, Zhu W, Ding Q, Wang S.
    Breast Cancer Res Treat; 2018 Jul 01; 170(2):257-270. PubMed ID: 29557526
    [Abstract] [Full Text] [Related]

  • 4. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X.
    Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225
    [Abstract] [Full Text] [Related]

  • 5. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K, Wang YY, Xu Y, Zhang L, Zhu J, Si PC, Wang YW, Ma R.
    Pathol Res Pract; 2021 Jun 15; 222():153458. PubMed ID: 33962174
    [Abstract] [Full Text] [Related]

  • 6. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W, Miao Y.
    Cancer Med; 2019 Jun 15; 8(6):2810-2822. PubMed ID: 31006985
    [Abstract] [Full Text] [Related]

  • 7. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH, Kim G, Kwak SG, Baek DW, Kang BW, Kim HJ, Park SY, Park JS, Choi GS, Hur K, Kim JG.
    Genes (Basel); 2021 Jan 27; 12(2):. PubMed ID: 33513887
    [Abstract] [Full Text] [Related]

  • 8. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
    Zhou X, Wen W, Shan X, Zhu W, Xu J, Guo R, Cheng W, Wang F, Qi LW, Chen Y, Huang Z, Wang T, Zhu D, Liu P, Shu Y.
    Oncotarget; 2017 Jan 24; 8(4):6513-6525. PubMed ID: 28036284
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
    Zou X, Xia T, Li M, Wang T, Liu P, Zhou X, Huang Z, Zhu W.
    Cancer Biomark; 2021 Jan 24; 30(1):41-53. PubMed ID: 32894240
    [Abstract] [Full Text] [Related]

  • 10. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
    Chiorino G, Petracci E, Sehovic E, Gregnanin I, Camussi E, Mello-Grand M, Ostano P, Riggi E, Vergini V, Russo A, Berrino E, Ortale A, Garena F, Venesio T, Gallo F, Favettini E, Frigerio A, Matullo G, Segnan N, Giordano L.
    Sci Rep; 2023 Jul 25; 13(1):12040. PubMed ID: 37491482
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma-based microRNA signatures in early diagnosis of breast cancer.
    Li X, Zou W, Wang Y, Liao Z, Li L, Zhai Y, Zhang L, Gu S, Zhao X.
    Mol Genet Genomic Med; 2020 May 25; 8(5):e1092. PubMed ID: 32124558
    [Abstract] [Full Text] [Related]

  • 13. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X.
    World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818
    [Abstract] [Full Text] [Related]

  • 14. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W.
    Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
    Fan X, Zou X, Liu C, Cheng W, Zhang S, Geng X, Zhu W.
    Biosci Rep; 2021 Jun 25; 41(6):. PubMed ID: 34076696
    [Abstract] [Full Text] [Related]

  • 17. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H, Zou X, Wu L, Zhang S, Wang T, Liu P, Zhu W, Zhu J.
    Cancer Med; 2020 Feb 25; 9(3):1230-1241. PubMed ID: 31856390
    [Abstract] [Full Text] [Related]

  • 18. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q, Gong W, Gu J, Geng G, Li T, Tian R, Yang Z, Zhang H, Shao L, Liu T, Wan L, Jia J, Yang C, Shi Y, Shi H.
    Front Immunol; 2018 Feb 25; 9():3099. PubMed ID: 30687316
    [Abstract] [Full Text] [Related]

  • 19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun 25; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 20. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
    Bitaraf A, Babashah S, Garshasbi M.
    J Clin Lab Anal; 2020 Feb 25; 34(2):e23063. PubMed ID: 31595567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.